Ehren Kilpatrick
Family · Warner Robins, GANPI 1487287447
Payments from drug & device makers
Across 204 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$490
- Amgen$433
- AstraZeneca$375
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$362
- Novo Nordisk$305
- Boehringer Ingelheim$249
- plus $2K from 30 others
What the payments were for
- Speaking & faculty fees$942%
- Food & beverage$3,71093%
- Education$1855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 8 | $490 |
| Amgen | 30 | $433 |
| AstraZeneca | 18 | $375 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $362 |
| Novo Nordisk | 22 | $305 |
| Boehringer Ingelheim | 14 | $249 |
| Paratek Pharmaceuticals, Inc. | 11 | $238 |
| Lilly USA, LLC | 10 | $174 |
| Esperion Therapeutics, Inc. | 8 | $139 |
| Antares Pharma, Inc. | 7 | $133 |
| CSL Behring | 2 | $99 |
| BD | 4 | $94 |
| AbbVie | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Exact Sciences | 4 | $70 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $68 |
| Novartis | 4 | $64 |
| Idorsia Pharmaceuticals US Inc | 3 | $63 |
| GSK | 2 | $46 |
| Smith+Nephew | 2 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| Tolmar, Inc. | 2 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Boston Scientific | 1 | $34 |
| Adlon Therapeutics L.p. | 2 | $27 |
| Pfizer | 1 | $24 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Merck | 1 | $18 |
| Halozyme Inc | 1 | $17 |
| UCB, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$263
How this compares
$3,989 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 55 | $55,139 |
| JanuviaSitagliptin Phosphate | 14 | $18,522 |
| FarxigaDapagliflozin Propanediol | 22 | $17,606 |
| EliquisApixaban | 15 | $16,554 |
| JardianceEmpagliflozin | 20 | $14,394 |
| MounjaroTirzepatide | 13 | $13,606 |
| RybelsusSemaglutide | 13 | $11,992 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,423 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $3,287 |
| Duloxetine Hcl | 20 | $1,465 |
| Estradiol | 17 | $899 |
| Levothyroxine Sodium | 95 | $813 |
| Colchicine | 13 | $649 |
| Diclofenac Sodium | 31 | $602 |
| Omeprazole | 44 | $545 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $305 | $67,13168 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $375 | $25,02934 claims |
| MerckJanuvia | $18 | $18,52214 claims |
| PfizerEliquis | $24 | $16,55415 claims |
| Boehringer IngelheimJardiance | $249 | $14,39420 claims |
| Lilly USA, LLCMounjaro | $174 | $13,60613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Warner Robins
- Kelly MurrayWarner Robins$18K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.